GlassScriptPhysician profile
Navin Raj
NPI 1033421706
$2,834.64
in general payments reported to CMS, 2019-2025
36 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $481 · 2021: $254 · 2022: $358 · 2023: $488 · 2024: $567 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,504 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,503.90 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $444.56 | 2020-2025 | Penmenvy, Arexvy, Shingrix |
| Lilly USA, LLC | $409.25 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $204.37 | 2020-2024 | Ozempic, Rybelsus |
| Abbvie INC. | $194.19 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $151.69 | 2024-2025 | Caplyta |
| Exact Sciences Corporation | $147.27 | 2023-2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $137.88 | 2019-2024 | |
| Pfizer INC. | $106.27 | 2019-2025 | |
| Sanofi Pasteur INC. | $99.56 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $97.06 | 2023-2024 | Breztri, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $81.42 | 2019-2025 | Xifaxan |
| Bausch Health US, LLC | $74.66 | 2021-2024 | Aplenzin, Wellbutrin |
| Mannkind Corporation | $59.40 | 2023 | Afrezza |
| Corium, LLC | $56.78 | 2023 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $53.21 | 2020-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $49.22 | 2020-2021 | |
| Cranial Technologies, INC | $48.44 | 2020-2025 | Doc Band |
| Abbott Laboratories | $46.35 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Takeda Pharmaceuticals U.S.A., INC. | $43.70 | 2020-2023 | Trintellix |
| Sanofi-Aventis U.S. LLC | $39.57 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $32.25 | 2022 | |
| Dexcom, INC. | $27.64 | 2022-2023 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $21.97 | 2024 | Inspire |
| Alk-Abello, INC | $21.78 | 2025 | Neffy |
| Irhythm Technologies, INC. | $19.34 | 2020 | |
| Ani Pharmaceuticals, INC. | $17.72 | 2023 | Purified Cortrophin Gel |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.47 | 2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $16.46 | 2021 | |
| Amneal Pharmaceuticals LLC | $16.07 | 2022 | |
| Philips North America LLC | $16.00 | 2020 | |
| Horizon Therapeutics Plc | $15.60 | 2022 | |
| Mayne Pharma Commercial LLC | $15.38 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $14.64 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.07 | 2022 | |
| Allergan, INC. | $12.09 | 2020 | |
| Amgen INC. | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Navin Raj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.